Ultrasound detects significantly low crystal deposition in gout by ULT: Study
Written By : Medha Baranwal
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2020-08-31 05:58 GMT | Update On 2020-08-31 05:58 GMT
Advertisement
Norway: A treat-to-target approach with urate lowering therapy caused a significant reduction of ultrasound-detected crystal depositions after 12 months in gout patients, according to a recent study in the Annals of the Rheumatic Diseases. Further, an ultrasound scoring system for crystal depositions was found to be sensitive to change.
Ultrasound is sensitive to changes for the detection of crystal deposition in gout patients. Hilde Berner Hammer, Department of Rheumatology, Diakonhjemmet Sykehus, Oslo, Norway, and colleagues explored the main locations for depositions and the extent of dissolution of depositions during a treat-to-target approach with urate-lowering treatment (ULT) in gout patients.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.